ArticleBMC palliative care2026
Criteria for referral to a hospital palliative care team in a cancer setting: a Delphi study of oncologists.
Article in BMC palliative care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProviding palliative care alongside cancer treatments enhances the quality of life and satisfaction with care for patients with cancer and their families. Determining the timing of referral can often be challenging, as oncologists typically make these decisions. We conducted a Delphi study to establish criteria for referring patients to hospital palliative care teams (HPCT).
methodsEighty-five oncologists were presented with 22 criteria developed from literature synthesis, categorised into seven domains, for referral to HPCT. Consensus development was predetermined, with a score of ≥ 7, as agreed upon by over 80% of the participants.
resultsIn the first round, 63 out of 85 participants (74%) responded, and in the second round, 41 out of 63 (65%) responded. During the initial round, consensus was reached on 14 out of 22 statements. Six statements were dropped, and two were revised for the next round. The final 14 criteria for HPCT referral were consolidated into ten criteria across five domains: (1) Cancer-related (stage 4 cancer, life expectancy of less than six months), (2) Treatment-related (failed two or more lines of treatment), (3) Symptom-related (ECOG ≥ 3, multiple symptoms including pain and comorbidities affecting patient quality of life, with scores of four or higher on the distress thermometer), (4) Patient preferences (requested palliative care, refused cancer-directed treatment, requested limitation of life-sustaining treatment), and (5) End-of-life care (perceived need for end-of-life care planning).
conclusionDeveloping a palliative care referral criterion provides a structured foundation for identifying cancer patients who might benefit from HPCT referral. Additional empirical validation is required to improve its clinical relevance and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.